Ottimo Pharma Revenue

Biotechnology Research • • 11-20 Employees

Ottimo Pharma revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	$140,000,000

Key Contacts at Ottimo Pharma

William Finlay

Co-Founder And Advisor

Phil Bardwell

Executive Director, Translational Sciences

Susan Singer

Director Of Executive Administration And Operations

Whitney Escalante

Associate Director, Clinical Operations

Company overview

Headquarters	XX
Website	ottimopharma.com
NAICS	541714
Founded	2020
Employees	11-20
Socials

Ottimo Pharma Email Formats

Ottimo Pharma uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@ottimopharma.com), used 60% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@ottimopharma.com	60%
{first name}{last name}	johndoe@ottimopharma.com	20%
{first initial}	j@ottimopharma.com	10%
{last name}{last name}	doedoe@ottimopharma.com	10%

About Ottimo Pharma

Ottimo Pharma is a private biotechnology company, co-founded in 2020 by Medicxi and Jonny Finlay, focused on the development of pioneering innovative cancer therapies for solid tumors. The Company's lead program, Jankistomig, is a PD1-VEGFR2 bi-functional antibody designed to target both immune checkpoint inhibition and angiogenesis in a single IgG therapy. By advancing this dual-pathway approach, Ottimo Pharma aims to improve cancer treatment outcomes and reduce overall healthcare burden. The Company boasts a world-class leadership team, including David Epstein as Chair and CEO, Mehdi Shahidi as Head of Development and CMO, and James Sabry as Vice-Chair of the Board. Ottimo Pharma anticipates filing an IND in late 2025.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Vice President

Director

Entry

Employees by Department

Ottimo Pharma has 10 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Ottimo Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-11-28	3	N/A
2025-01-19	4	$140,000,000

Funding Insights

$140,000,000

Total funding amount

$140,000,000

Most recent funding amount

Number of funding rounds

Ottimo Pharma Tech Stack

Discover the technologies and tools that power Ottimo Pharma's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Sectigo

SSL/TLS certificate authorities

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Microsoft 365

Frequently asked questions

Ottimo Pharma is located in XX.

Ottimo Pharma generates an estimated annual revenue of $1,711,100. This revenue figure reflects the company's market position and business performance in its industry.

Ottimo Pharma has an estimated valuation of $5,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Ottimo Pharma was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Ottimo Pharma has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Ottimo Pharma has raised a total of $140,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.